PMC:7091888 / 89-770 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"34","span":{"begin":436,"end":441},"obj":"Gene"},{"id":"35","span":{"begin":677,"end":678},"obj":"Gene"},{"id":"36","span":{"begin":316,"end":363},"obj":"Species"},{"id":"37","span":{"begin":365,"end":375},"obj":"Species"},{"id":"38","span":{"begin":392,"end":414},"obj":"Species"},{"id":"39","span":{"begin":416,"end":425},"obj":"Species"},{"id":"40","span":{"begin":432,"end":435},"obj":"Species"},{"id":"41","span":{"begin":666,"end":676},"obj":"Species"},{"id":"53","span":{"begin":105,"end":129},"obj":"Disease"},{"id":"54","span":{"begin":131,"end":139},"obj":"Disease"},{"id":"55","span":{"begin":282,"end":291},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"Gene:43740568"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"Gene:43740568"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"Tax:2697049"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"Tax:2697049"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"Tax:2697049"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:2697049"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"Tax:11118"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"Tax:2697049"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:C000657245"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:C000657245"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ion for development of RBD protein as a viral attachment inhibitor and vaccine\n\nAbstract\nThe outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, calling for the development of safe and effective prophylactics and therapeutics against infection of its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV). The CoV spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines. Here, we identified the receptor-binding domain (RBD) in SARS-CoV-2 S pr"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":27,"end":34},"obj":"Body_part"},{"id":"T2","span":{"begin":446,"end":453},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"ion for development of RBD protein as a viral attachment inhibitor and vaccine\n\nAbstract\nThe outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, calling for the development of safe and effective prophylactics and therapeutics against infection of its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV). The CoV spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines. Here, we identified the receptor-binding domain (RBD) in SARS-CoV-2 S pr"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":105,"end":129},"obj":"Disease"},{"id":"T2","span":{"begin":131,"end":139},"obj":"Disease"},{"id":"T3","span":{"begin":282,"end":291},"obj":"Disease"},{"id":"T4","span":{"begin":316,"end":363},"obj":"Disease"},{"id":"T5","span":{"begin":316,"end":349},"obj":"Disease"},{"id":"T6","span":{"begin":365,"end":373},"obj":"Disease"},{"id":"T7","span":{"begin":365,"end":369},"obj":"Disease"},{"id":"T8","span":{"begin":666,"end":674},"obj":"Disease"},{"id":"T9","span":{"begin":666,"end":670},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ion for development of RBD protein as a viral attachment inhibitor and vaccine\n\nAbstract\nThe outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, calling for the development of safe and effective prophylactics and therapeutics against infection of its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV). The CoV spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines. Here, we identified the receptor-binding domain (RBD) in SARS-CoV-2 S pr"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":38,"end":39},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":141,"end":144},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T3","span":{"begin":151,"end":152},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":538,"end":539},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ion for development of RBD protein as a viral attachment inhibitor and vaccine\n\nAbstract\nThe outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, calling for the development of safe and effective prophylactics and therapeutics against infection of its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV). The CoV spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines. Here, we identified the receptor-binding domain (RBD) in SARS-CoV-2 S pr"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":27,"end":34},"obj":"Chemical"},{"id":"T2","span":{"begin":57,"end":66},"obj":"Chemical"},{"id":"T3","span":{"begin":446,"end":453},"obj":"Chemical"},{"id":"T4","span":{"begin":584,"end":594},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"ion for development of RBD protein as a viral attachment inhibitor and vaccine\n\nAbstract\nThe outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, calling for the development of safe and effective prophylactics and therapeutics against infection of its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV). The CoV spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines. Here, we identified the receptor-binding domain (RBD) in SARS-CoV-2 S pr"}

{"project":"LitCovid-sentences","denotations":[{"id":"T2","span":{"begin":80,"end":88},"obj":"Sentence"},{"id":"T3","span":{"begin":89,"end":427},"obj":"Sentence"},{"id":"T4","span":{"begin":428,"end":608},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ion for development of RBD protein as a viral attachment inhibitor and vaccine\n\nAbstract\nThe outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, calling for the development of safe and effective prophylactics and therapeutics against infection of its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV). The CoV spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines. Here, we identified the receptor-binding domain (RBD) in SARS-CoV-2 S pr"}